Tianjin Pharmaceutical

Tianjin Pharmaceutical specializes in the development of oral liquid products and sales services.

Number of Funding Rounds

Total Funding Amount

4

¥63M

Tianjin Pharmaceutical has raised a total of ¥63M in funding over 2 rounds. Their latest funding was raised on Mar 12, 2018 from a Series C round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Mar 12, 2018	Series C	¥30M	1	Tianxin Shiye	—	Detail
Jan 28, 2015	Series B	¥20M	1	Sunz Fund	—	Detail
Jun 30, 1998	Series A	¥10M	1	—	—	Detail
Jun 30, 1997	Angel	¥3M	2	—	—	Detail

Number of Lead Investors

Number of Investors

2

5

Tianjin Pharmaceutical is funded by 5 investors. Tianxin Shiye and Sunz Fund are the most recent investors.

Investor Name	Lead Investor	Funding Round
Tianxin Shiye	Yes	Series C
Sunz Fund	Yes	Series B
Guangzhou Begol Holdings	—	Series A
Modern Agricultural Industry Holding Group	—	Angel
Shanruntang Biotechnology	—	Angel